<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="94101">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01919255</url>
  </required_header>
  <id_info>
    <org_study_id>NCC-CAN-001</org_study_id>
    <nct_id>NCT01919255</nct_id>
  </id_info>
  <brief_title>Evaluation of PICOLIGHT Plus COOLPREP, PICOLIGHT Plus CLICOLON for Bowel Preparation</brief_title>
  <official_title>Evaluation of PICOLIGHT Plus COOLPREP, PICOLIGHT Plus CLICOLON for Bowel Preparation (The Phase II Prospective Randomized Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <authority>Korea: National Cancer Center</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study to bowel cleansing evaluation of mixed two other type bowel
      preparation drug(PICOLIGHT plus COOLPREP, PICOLIGHT plus CLICOLON).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate mixed-drug bowel preparation methods for decreasing side effect and increasing
      compliance

      Picolight + Coolprep [Day-Prior] Picolight + Clicolon [Day-Prior] Picolight + Coolprep
      [Split-Dose] Picolight + Clicolon [Split-Dose]
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening</study_design>
  <primary_outcome>
    <measure>Bowel preparation quality</measure>
    <time_frame>the day of colonoscopy</time_frame>
    <safety_issue>No</safety_issue>
    <description>Aronchick bowel preparation score;
Excellent: small volume of clear liquid or greater than 95% of surface seen
Good: large volume of clear liquid 5% to 25% of the surface but greater than 90% of surface seen
Fair: some semi-solid stool that could be suctioned or washed away, but greater than 90% of surface seen
Poor: semi-solid stool that could not be suctioned or washed away and less than 90% of surface seen
Inadequate: re-preparation needed
(* 'success' of bowel preparation is defined as Aronchick's 'Excellent' or 'Good'.)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient tolerance</measure>
    <time_frame>the  day of colonoscopy</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient's tolerance;
1= &quot;none&quot;; 2= &quot;mild&quot;; 3= &quot;bothersome&quot;; 4= &quot;distressing&quot;; 5= &quot;severely distressing&quot;</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Adenoma detection rate</measure>
    <time_frame>The day of colonoscopy</time_frame>
    <safety_issue>No</safety_issue>
    <description>Adenoma detection rate (%)</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">236</enrollment>
  <condition>Healthy</condition>
  <condition>Screenee</condition>
  <arm_group>
    <arm_group_label>Picolight + Coolprep (Day-Prior)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Picolight (1p/250cc, 5PM) + Coolprep (500cc x 2, 8PM)[Day-Prior]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Picolight +  Clicolon (Day-Prior)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Picolight (1p/250cc, 5PM) + Clicolon (4T x 4, 8PM) [Day-Prior]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Picolight + Coolprep (Split-Dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Picolight (1p/250cc, 7PM) + Coolprep (500cc x 2, 5AM)[Split-Dose]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Picolight + Clicolon (Split-Dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Picolight (1p/250cc, 7PM) + Clicolon (4T x 4, 5AM)[Split-Dose]</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Picolight + Coolprep</intervention_name>
    <description>Picolight (1p/250cc, 5PM) + Coolprep (500cc x 2, 8PM)[Day-Prior] Picolight (1p/250cc, 7PM) + Coolprep (500cc x 2, 5AM)[Split-Dose]</description>
    <arm_group_label>Picolight + Coolprep (Day-Prior)</arm_group_label>
    <arm_group_label>Picolight + Coolprep (Split-Dose)</arm_group_label>
    <other_name>Picolight(Citric acid, Magnesium Oxide, Sodium picosulfate)</other_name>
    <other_name>Coolprep(PEG 3350 + EL, Ascobic acid, Sodium sulfate)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Picolight + Clicolon</intervention_name>
    <description>Picolight (1p/250cc, 5PM) + Clicolon (4T x 4, 8PM) [Day-Prior] Picolight (1p/250cc, 7PM) + Clicolon (4T x 4, 5AM)[Split-Dose]</description>
    <arm_group_label>Picolight +  Clicolon (Day-Prior)</arm_group_label>
    <arm_group_label>Picolight + Clicolon (Split-Dose)</arm_group_label>
    <other_name>Picolight(Citric acid, Magnesium Oxide, Sodium picosulfate)</other_name>
    <other_name>Clicolon(Sodium phosphate)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20-65 years of age

          -  Elective colonoscopy of outpatients(consent to the study)

        Exclusion Criteria:

          -  Active enteritis, enteric bleeding, obstruction

          -  Pregnant or lactating women

          -  Severe liver or renal insufficiency

          -  Allergic to any preparation components

          -  History of heart disease (ischemic heart disease, congestive heart failure,
             arrythmia)

          -  History of colorectal surgery

          -  History abdominal surgery within 6 month

          -  Toxic colitis or megacolon

          -  Nausea or vomiting

          -  Status emergent abdominal surgery (ex. acute appendicitis)

          -  Uncontrolled clinically significant pre-existing electrolyte disturbance

          -  Dehydration

          -  Phenylketonuria

          -  Glucose-6-phosphate dehydrogenase deficiency

          -  Ileus

          -  Suspicious hyperphosphatemia

          -  Acute phosphate nephropathy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dae Kyung Sohn</last_name>
    <role>Principal Investigator</role>
    <affiliation>NCC,Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dae Kyung Sohn, MD, PHD</last_name>
    <phone>+82‐31‐920‐1636</phone>
    <email>gsgsbal@ncc.re.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tae Young Chang, MD</last_name>
    <phone>+82‐31‐920‐1761</phone>
    <email>12010@ncc.re.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dae Kyung Sohn</name>
      <address>
        <city>Goyang-si</city>
        <state>Gyeonggi-do</state>
        <zip>410-769</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dae Kyung Sohn, MD,PHD</last_name>
      <phone>+82‐31‐920‐1636</phone>
      <email>gsgsbal@ncc.re.kr</email>
    </contact>
    <contact_backup>
      <last_name>Tae Young Chang</last_name>
      <phone>+82‐31‐920‐1761</phone>
      <email>12010@ncc.re.kr</email>
    </contact_backup>
    <investigator>
      <last_name>Hyo Jae Won</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 14, 2014</lastchanged_date>
  <firstreceived_date>August 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Dae Kyung Sohn</investigator_full_name>
    <investigator_title>MD., PHD, Center for Colorectal Cancer</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Bowel preparation</keyword>
  <keyword>Picolight</keyword>
  <keyword>Clicolon</keyword>
  <keyword>Coolprep</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Magnesium Oxide</mesh_term>
    <mesh_term>Picosulfate sodium</mesh_term>
    <mesh_term>Sodium phosphate</mesh_term>
    <mesh_term>Sodium sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
